Stockholm3 Prostate Cancer Test Outperforms PSA Screening - Top-Institutions - MDSpire

Stockholm3 Prostate Cancer Test Outperforms PSA Screening

Population-based study suggests risk-based screening identifies more clinically significant prostate cancers than age-based PSA thresholds

  • July 3, 2026

  • 3 min

Share

Top Institutions in Pathology

Brief introduction explaining scope and methodology.

  • #1

    German Cancer Research Centre (DKFZ)
    German Cancer Research Centre (DKFZ)

    Heidelberg, Baden-Württemberg

    Key Differentiators

    • Urology
    • Oncology

  • #2

    Karolinska Institute
    Karolinska Institute

    Stockholm, Stockholm

    Key Differentiators

    • Urology
    • Medicine

Original Source(s)

Stockholm3 Prostate Cancer Test Outperforms PSA Screening

  • July 3, 2026

Related Content

Editorial: Characterising the functional heterogeneity of synovial macrophages

Medical Oddities: Do Jellyfish Hold a Healing Secret?

Jellyfish, pets, watermelon, brain implants, and fennel fuel this week's surprises.

Durable stable disease and immune activation in metastatic uveal melanoma treated with tebentafusp: case report